← Back to Search

Neurofeedback

Measuring the Impact of Real Time fMRI Neurofeedback in Borderline Personality Disorder

N/A
Waitlist Available
Led By Michelle Hampson, PhD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline compared to the week after intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new method called real-time fMRI neurofeedback in people with Borderline Personality Disorder. It aims to help them control their brain activity by showing them real-time images of their brain. This approach could offer a new way to manage BPD symptoms. Real-time fMRI neurofeedback is an emerging technique that allows individuals to learn voluntary control over their brain activity, which has shown potential therapeutic effects in neurological and psychiatric conditions.

Eligible Conditions
  • Borderline Personality Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline compared to the week after intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline compared to the week after intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Affective Lability
Secondary study objectives
Change in Amygdala Regulation
Change in Borderline Personality Disorder Symptoms
Change in Mean Negative Affect

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
Neurofeedback in conjunction with Dialectical Behavior Therapy
Group II: ControlActive Control1 Intervention
Dialectical Behavior Therapy (treatment as usual)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
real time fMRI neurofeedback
2020
N/A
~10

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,927 Previous Clinical Trials
3,031,729 Total Patients Enrolled
5 Trials studying Borderline Personality Disorder
232 Patients Enrolled for Borderline Personality Disorder
AE FoundationOTHER
2 Previous Clinical Trials
144 Total Patients Enrolled
2 Trials studying Borderline Personality Disorder
144 Patients Enrolled for Borderline Personality Disorder
Central Institute of Mental Health, MannheimOTHER
72 Previous Clinical Trials
8,370 Total Patients Enrolled
4 Trials studying Borderline Personality Disorder
267 Patients Enrolled for Borderline Personality Disorder
Michelle Hampson, PhDPrincipal InvestigatorYale University
3 Previous Clinical Trials
135 Total Patients Enrolled
Sarah K Fineberg, MD PhDPrincipal InvestigatorYale University
1 Previous Clinical Trials
150 Total Patients Enrolled
1 Trials studying Borderline Personality Disorder
150 Patients Enrolled for Borderline Personality Disorder
~1 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top